Healthcare provider profile · identity verified

Georgina Green

Family Practice · KANSAS CITY, MO · NPI 1114309358

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	875	211
Levothyroxine Sodium	Levothyroxine Sodium	671	133
Lisinopril	Lisinopril	564	128
Omeprazole	Omeprazole	524	115
Amlodipine Besylate	Amlodipine Besylate	517	124
Losartan Potassium	Losartan Potassium	512	114
Pantoprazole Sodium	Pantoprazole Sodium	363	70
Metformin Hcl Er	Metformin Hcl	356	75
Gabapentin	Gabapentin	315	76
Rosuvastatin Calcium	Rosuvastatin Calcium	272	65
Metoprolol Succinate	Metoprolol Succinate	256	58
Simvastatin	Simvastatin	242	50
Metformin Hcl	Metformin Hcl	237	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	231	30
Sertraline Hcl	Sertraline Hcl	226	47
Hydrochlorothiazide	Hydrochlorothiazide	222	47
Famotidine	Famotidine	216	40
Albuterol Sulfate Hfa	Albuterol Sulfate	166	48
Trazodone Hcl	Trazodone Hcl	164	44
Montelukast Sodium	Montelukast Sodium	159	27
Furosemide	Furosemide	155	34
Tamsulosin Hcl	Tamsulosin Hcl	144	35
Eliquis	Apixaban	141	28
Potassium Chloride	Potassium Chloride	139	27
Pravastatin Sodium	Pravastatin Sodium	128	25
Duloxetine Hcl	Duloxetine Hcl	124	26
Carvedilol	Carvedilol	122	31
Warfarin Sodium	Warfarin Sodium	122	17
Jardiance	Empagliflozin	119	23
Fluticasone Propionate	Fluticasone Propionate	118	36
Meloxicam	Meloxicam	111	31
Escitalopram Oxalate	Escitalopram Oxalate	107	30
Alendronate Sodium	Alendronate Sodium	103	26
Tramadol Hcl	Tramadol Hcl	98	21
Mirtazapine	Mirtazapine	96	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	92	19
Atenolol	Atenolol	91	20
Clopidogrel	Clopidogrel Bisulfate	91	14
Ozempic	Semaglutide	91	15
Tizanidine Hcl	Tizanidine Hcl	91	28
Spironolactone	Spironolactone	89	18
Buspirone Hcl	Buspirone Hcl	77	24
Allopurinol	Allopurinol	76	19
Metoprolol Tartrate	Metoprolol Tartrate	76	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	76	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	18
Oxycodone Hcl	Oxycodone Hcl	73	14
Pregabalin	Pregabalin	72	suppressed
Glipizide Er	Glipizide	69	13
Fluoxetine Hcl	Fluoxetine Hcl	68	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	13
Ezetimibe	Ezetimibe	62	13
Mounjaro	Tirzepatide	62	suppressed
Diclofenac Sodium	Diclofenac Sodium	58	14
Trulicity	Dulaglutide	55	suppressed
Sucralfate	Sucralfate	54	13
Finasteride	Finasteride	51	11
Synthroid	Levothyroxine Sodium	49	14
Paroxetine Hcl	Paroxetine Hcl	48	11
Citalopram Hbr	Citalopram Hydrobromide	47	16
Estradiol	Estradiol	46	24
Hydralazine Hcl	Hydralazine Hcl	46	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	46	12
Morphine Sulfate Er	Morphine Sulfate	45	suppressed
Januvia	Sitagliptin Phosphate	42	suppressed
Enalapril Maleate	Enalapril Maleate	41	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Alprazolam	Alprazolam	39	11
Esomeprazole Magnesium	Esomeprazole Magnesium	39	suppressed
Fenofibrate	Fenofibrate	38	suppressed
Cephalexin	Cephalexin	37	30
Donepezil Hcl	Donepezil Hcl	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	35	suppressed
Glipizide	Glipizide	35	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Clonazepam	Clonazepam	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Clotrimazole	Clotrimazole	27	17
Linzess	Linaclotide	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	14
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	22
Azelastine Hcl	Azelastine Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Nystatin	Nystatin	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Prednisone	Prednisone	22	14
Topiramate	Topiramate	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Baclofen	Baclofen	20	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Ciclopirox	Ciclopirox Olamine	18	suppressed
Diazepam	Diazepam	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Colestipol Hcl	Colestipol Hcl	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Primidone	Primidone	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Betamethasone Valerate	Betamethasone Valerate	16	suppressed
Mupirocin	Mupirocin	16	11
Sotalol	Sotalol Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Naproxen	Naproxen	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Novolog	Insulin Aspart	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Trandolapril	Trandolapril	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Azathioprine	Azathioprine	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Azithromycin	Azithromycin	11	11
Carbamazepine	Carbamazepine	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error